Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04150328 · ClinicalTrials.gov registry record
Lenalidomide Monotherapy in R/R DLBCL
A clinical trial, sponsored by MorphoSys.
- Completed
- Registry status
- 490
- Enrollment target
NCT04150328 is a clinical trial that has completed, run by MorphoSys. The registered enrollment target is 490 participants.
The verdict
NCT04150328 has completed, sponsored by MorphoSys.
- COMPLETED
- Registry status
- 490 participants
- Enrollment target
Study Summary
This observational study is designed to characterise the effectiveness of lenalidomide monotherapy in the treatment of R/R DLBCL and to compare the results with the efficacy outcomes of a tafasitamab-lenalidomide combination therapy in the clinical trial MOR208C203 (L-MIND)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 490 participants |
| Start Date | 2019-04-12 |
| Est. Completion | 2020-08-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04150328
The ClinicalTrials.gov registry entry for NCT04150328 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 490 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MorphoSys, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04150328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04150328 about?
NCT04150328 is a clinical study titled "Lenalidomide Monotherapy in R/R DLBCL". This observational study is designed to characterise the effectiveness of lenalidomide monotherapy in the treatment of R/R DLBCL and to compare the results with the efficacy outcomes of a tafasitamab-lenalidomide combination therapy in the clinical trial MOR208C203 (L-MIND)
What is the current status of trial NCT04150328?
This trial is currently completed. The enrollment target is 490 participants. The study started on 2019-04-12. Estimated completion is 2020-08-25.
Who is sponsoring clinical trial NCT04150328?
This trial is sponsored by MorphoSys, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.